Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.59 |
| ▸ | TFPI | P10646 | 1/20 | 0.56 |
| ▸ | GLP1R | P43220 | 3/20 | 0.56 |
| ▸ | GCGR | P47871 | 1/20 | 0.56 |
| ▸ | GIPR | P48546 | 1/20 | 0.56 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | CALCR | P30988 | 3/20 | 0.54 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | BACE1 | P56817 | 1/20 | 0.53 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30903271 | 0.93 | IL23R (0.53) | IL23RTFPIGLP1RGCGRGIPR | |
| SCHEMBL29609357 | 0.92 | TFPI (0.64) | IL23RTFPIGLP1RGCGRGIPR | |
| SCHEMBL31182935 | 0.92 | TFPI (0.62) | IL23RTFPIGLP1RGCGRGIPR | |
| SCHEMBL31182918 | 0.91 | TFPI (0.64) | IL23RTFPIGLP1RGCGRGIPR | |
| SCHEMBL29811062 | 0.90 | IL23R (0.59) | IL23RTFPIGLP1RGCGRGIPR | |
| SCHEMBL30903269 | 0.90 | IL23R (0.53) | IL23RTFPIGLP1RGCGRGIPR | |
| SCHEMBL29696462 | 0.90 | OPRM1 (0.60) | IL23RTFPIKEAP1OPRM1OPRD1 | |
| SCHEMBL29649226 | 0.90 | VIPR2 (0.60) | TFPIGLP1RVIPR2CALCRVIPR1 | |
| SCHEMBL29836442 | 0.89 | TFPI (0.55) | IL23RTFPIGLP1RVIPR2OPRM1 | |
| SCHEMBL29461526 | 0.89 | IL23R (0.53) | IL23RTFPIGLP1RGCGRGIPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248816-A9 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-08-10 | — | — | US | disclosed |
| US-20230066762-A1 | IMMUNOGENIC COMPOSITION | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-03-02 | — | — | US | disclosed |
| US-20220288190-A1 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220288190-A1 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | CFD, PEPD, SERPINA6 | IL23R 1762/4885TFPI 1391/4885GLP1R 2107/4885 |
| US-20230248816-A9 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | CFD, PEPD, SERPINA6 | IL23R 1762/4885TFPI 1391/4885GLP1R 2107/4885 |
| US-20230066762-A1 | IMMUNOGENIC COMPOSITION | CXCL10, CCL2, CCL11 | IL23R 520/4885TFPI 3568/4885GLP1R 2834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.